The healthcare provider prescribes bismuth subsalicylate, metronidazole, tetracycline, and pantoprazole for a client with a Helicobacter pylori (H. pylori) infection.
Prior to administering the
H. pylori treatment regimen, the nurse should review the electronic medical record for which medication?
A.
Famotidine.
B.
Loperamide.
C.
Aspirin.
D.
Ipratropium.
The Correct answer and Explanation is:
The correct answer is C. Aspirin.
Explanation:
When treating a client for a Helicobacter pylori (H. pylori) infection, particularly with the prescribed regimen of bismuth subsalicylate, metronidazole, tetracycline, and pantoprazole, the nurse should pay special attention to the potential interactions and contraindications associated with these medications. Bismuth subsalicylate contains salicylate, which is chemically similar to aspirin.
- Bismuth Subsalicylate and Aspirin: Since bismuth subsalicylate contains salicylate, administering it concurrently with aspirin can increase the risk of salicylate toxicity. This toxicity can manifest as tinnitus, dizziness, gastrointestinal bleeding, and metabolic acidosis. Given that both medications may have similar side effects and can impact gastrointestinal function, it is critical to ensure that the client is not concurrently taking aspirin or other salicylates.
- Metronidazole and Tetracycline: Both metronidazole and tetracycline are antibiotics effective against H. pylori. They do not have significant interactions with aspirin, but their efficacy can be compromised in certain gastrointestinal conditions exacerbated by salicylate use.
- Pantoprazole: This proton pump inhibitor is prescribed to reduce stomach acid and promote healing of the gastric mucosa. It is generally safe to use with both metronidazole and tetracycline, but the impact of aspirin on gastric mucosa healing is a concern.
- Famotidine and Ipratropium: Famotidine is an H2 receptor antagonist that can reduce stomach acid but does not interact significantly with the prescribed antibiotics. Ipratropium is an anticholinergic medication for respiratory conditions and is unrelated to H. pylori treatment.
In summary, the nurse must review the electronic medical record for aspirin to prevent the potential for adverse effects due to increased salicylate levels when treating for H. pylori, ensuring the safety and efficacy of the treatment regimen.